Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Breakthrough Prize in Life Sciences

People with blue dots

Can you survive without the blue dot?

Or has the digital world has replaced our brain

Page & Page and Partners

- PMLiVE

Acceleron scraps rare muscular dystrophy drug

Clinical profile not strong enough to push into late-stage testing

- PMLiVE

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Could acquire up to 11 Roivant spinouts

armadillo in chains

Should there be a punishment?

I mean for people who use the word innovation willy-nilly.Is it just us here at P&P, or has the word lost its meaning? Dictionaries define it as a new idea...

Page & Page and Partners

- PMLiVE

Chi-Med cues up two more regulatory filings in cancer

Hong Kong based firm reports strong sales in first marketed product

- PMLiVE

Biogen grows in Q2, but Spinraza performance a concern

Company banking on pipeline readouts and Tecfidra defence

Diagnosing the lag in neuropsychiatric treatments

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop...

Blue Latitude Health

- PMLiVE

Boehringer bolsters NASH pipeline with $870m Yuhan deal

Strengthens existing relationship

- PMLiVE

Scancell preps phase 2 challenge for melanoma vaccine

Progress continues for biotech

MIT reveals new pill to deliver insulin

A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...

Blue Latitude Health

- PMLiVE

UK financial authority confirms Woodford probe

Biotech investor in cross-hairs

- PMLiVE

Ogilvy Health UK launches workplace learning company

Tailors learning to pharma industry roles

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links